安迪苏(600299) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 reached ¥4,114,999,156, representing a year-on-year increase of 25.23%[2] - The net profit attributable to shareholders for the same period was ¥395,680,221, with a year-to-date net profit of ¥1,003,279,525, reflecting an 18.32% increase compared to the previous year[2] - The basic earnings per share for Q3 2024 was ¥0.15, while the diluted earnings per share was also ¥0.15[3] - Operating profit for the third quarter was CNY 1,378,171,752, a significant recovery from a loss of CNY 11,697,240 in the previous year[20] - Net profit attributable to shareholders of the parent company for the third quarter was CNY 1,003,279,525, compared to a loss of CNY 34,405,991 in the same quarter of 2023[20] - The total comprehensive income for the third quarter of 2024 reached CNY 950,427,428, a significant increase from CNY 135,781,435 in the same period of 2023[21] - Basic and diluted earnings per share for the third quarter were CNY 0.37, compared to a loss of CNY 0.01 in the previous year[21] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥22,269,982,178, a 3.52% increase from the end of the previous year[3] - As of September 30, 2024, the total assets of the company reached RMB 22,269,982,178, an increase from RMB 21,513,367,642 at the end of 2023, representing a growth of approximately 3.5%[14] - The company's current assets amounted to RMB 6,355,563,757, up from RMB 5,398,557,917, indicating a growth of about 17.7% year-over-year[16] - Total liabilities decreased slightly to CNY 6,415,600,329 from CNY 6,448,499,145 year-over-year[18] - The company's total liabilities decreased to RMB 6,355,563,757 from RMB 6,398,557,917, reflecting a slight reduction of about 0.7%[16] Cash Flow - The company reported a net cash flow from operating activities of ¥2,220,971,908 year-to-date, which is a 23.86% increase compared to the previous year[2] - Cash flow from operating activities generated a net amount of CNY 2,220,971,908, up from CNY 1,793,194,702 year-over-year[22] - Total cash inflow from operating activities was CNY 11,499,228,102, compared to CNY 10,642,920,851 in the prior year[22] - Cash outflow from operating activities totaled CNY 9,278,256,194, an increase from CNY 8,849,726,149 in the previous year[22] - Cash flow from investing activities resulted in a net outflow of CNY 1,177,816,244, slightly improved from CNY 1,259,556,441 in the same period last year[22] - Cash flow from financing activities showed a net outflow of CNY 722,744,647, compared to CNY 391,823,440 in the previous year[23] - The ending balance of cash and cash equivalents was CNY 1,334,456,897, up from CNY 958,125,006 at the end of the third quarter of 2023[23] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 26,607, with the largest shareholder holding 63.74% of the shares[7] - The company has not reported any significant changes in shareholder participation in margin trading or securities lending activities during the reporting period[12] Operational Insights - The company plans to continue optimizing its supply chain and cost management strategies to enhance profitability amid challenging market conditions[6] - The company has maintained a strong growth trajectory in its methionine business, contributing positively to net profit increases[6] Other Financial Metrics - The weighted average return on equity increased by 5.22 percentage points to 4.77% for Q3 2024, and by 6.84 percentage points to 6.61% year-to-date[3] - Research and development expenses for the first three quarters were CNY 300,385,838, slightly down from CNY 302,063,643 in the same period last year[19] - The company reported a significant increase in tax expenses, totaling CNY 298,297,006 compared to CNY 16,724,666 in the previous year[20] - Other comprehensive income after tax for the third quarter was a loss of CNY 53,127,064, contrasting with a gain of CNY 170,581,176 in the same quarter of 2023[20] - The total equity attributable to shareholders of the parent company increased to CNY 15,826,425,091 from CNY 15,036,928,489 year-over-year[18]